Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44022918HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TVIS44029644HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TVIS44020046HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TVIS44020047HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TVIS44020048HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TVIS44020049HTLV-1ENSG00000156103.16protein_codingMMP16NoNo4325P51512
TCGA Plot Options
Drug Information
GeneMMP16
DrugBank IDDB00786
Drug NameMarimastat
Target IDBE0001637
UniProt IDP51512
Regulation Typeinhibitor
PubMed IDs10852638; 10669951
CitationsHeath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55.@@Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and clinical studies. Int J Biol Markers. 1999 Oct-Dec;14(4):232-8.
GroupsInvestigational
Direct ClassificationSecondary alcohols
SMILESCNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
Pathways
PharmGKBPA164748329
ChEMBLCHEMBL279785